
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
NexGel Inc Warrant (NXGLW)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: NXGLW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -91.96% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.52 | 52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 |
52 Weeks Range 0.22 - 0.95 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.39 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.7% | Operating Margin (TTM) -27.69% |
Management Effectiveness
Return on Assets (TTM) -20.77% | Return on Equity (TTM) -60.08% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 6447417 |
Shares Outstanding - | Shares Floating 6447417 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
NexGel Inc Warrant
Company Overview
History and Background
NexGel, Inc. is a hydrogel technology company. The warrants relate to ownership of the underlying stock. Detailed history is intertwined with NexGel's business operations, but specifically for the warrants, they represent a right to purchase stock at a predetermined price and time frame. Significant milestones would be tied to the issuance and expiration terms of the warrants.
Core Business Areas
- Hydrogels: NexGel develops and manufactures high water content, cross-linked polymer networks. These are used in a range of applications including wound care, cosmetics, and diagnostics.
Leadership and Structure
NexGel's leadership team would include a CEO, CFO, and potentially a Chief Scientific Officer or equivalent. The organizational structure will be typical of a small publicly traded company with functional departments such as R&D, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Wound Care Hydrogels: NexGel's hydrogels are used in advanced wound dressings for burns, ulcers, and surgical sites. Market share data specific to NexGel is likely limited. Competitors include 3M (MMM), Smith & Nephew (SNN), and Convatec (CVA).
- Cosmetic Hydrogels: Hydrogels incorporated into cosmetic and personal care products to deliver moisture and active ingredients. Market Share data is limited for NexGel. Key competitors include Ashland (ASH), BASF (BASFY), and Evonik (EVKIF).
Market Dynamics
Industry Overview
The hydrogel market is growing driven by demand in wound care, drug delivery, and personal care. The industry is competitive and innovation-focused.
Positioning
NexGel positions itself as a technology innovator in hydrogels, focusing on unique properties and applications. Its competitive advantage would lie in its proprietary formulations and manufacturing processes.
Total Addressable Market (TAM)
The global hydrogel market is estimated to be billions of dollars and growing. NexGel is positioning to capture market share with unique product offerings in their particular application segments.
Upturn SWOT Analysis
Strengths
- Proprietary Hydrogel Technology
- Strong focus on innovation
- Diverse application potential
- Experienced management team
Weaknesses
- Limited financial resources
- Small Market Share
- Dependence on key partnerships
- Limited brand recognition
Opportunities
- Expanding into new markets
- Developing strategic partnerships
- Acquiring complementary technologies
- Increasing demand for advanced wound care
Threats
- Competition from larger companies
- Regulatory hurdles
- Economic downturns
- Raw Material Price Increases
Competitors and Market Share
Key Competitors
- MMM
- SNN
- CVA
- ASH
- BASFY
- EVKIF
Competitive Landscape
NexGel's advantages lie in its innovative hydrogel technology, but its disadvantages are related to scale and market presence compared to larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth would depend on specific product launches and market penetration. Typically, this would involve analysis of revenue, market share, and profit.
Future Projections: Future growth projections would depend on analyst estimates for the hydrogel market and NexGel's ability to capture market share with its technology.
Recent Initiatives: Recent initiatives could include product development, partnership agreements, and expansion into new geographies.
Summary
NexGel Inc. Warrant's value is contingent on the performance of the underlying stock, NexGel, Inc. The company operates in the growing hydrogel market and has innovative technology, but faces stiff competition from larger, more established players. Its growth potential depends on successful commercialization and strategic partnerships. Investors should carefully consider the terms of the warrants and the financial health of NexGel Inc. before investing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NexGel Inc Warrant
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com |
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.